We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Calculus Vct Plc | LSE:CLC | London | Ordinary Share | GB00BYQPF348 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 60.00 | 50.00 | 70.00 | 60.00 | 60.00 | 60.00 | 312,631 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Investment Advice | 1.53M | 648k | 0.0105 | 57.14 | 37.04M |
Date | Subject | Author | Discuss |
---|---|---|---|
16/7/2007 15:58 | I thought that was my 250k... | diku | |
09/7/2007 20:13 | I put my money where my mouth was and purchased 250k today. Directors sound very positive indeed. What a refreshing change. | stingray steve | |
08/7/2007 17:46 | These do look rather undervalued at these prices. | stingray steve | |
05/7/2007 18:09 | "highly geared" ????? MKT CAP = 2 million | william of orange | |
01/7/2007 13:56 | While I agree that this company looks interesting, the balance sheet is tenuous imo. On the plus side, there are minimal intangibles which, compared to many other similar companies, states their position more openly. However, the Brown Shipley loan relies on "personal guarantees" as collateral which I haven't investigated, although that at least indicates strong management confidence and commitment. The bottom line and balance sheet should also receive strong support from the recognition of deferred tax credits at some future date if/when conditions of foreseeable profitability (on a more likely than not basis) are achieved. That might require a couple of years of sustained and growing profitabilty but could well be anticipated in the share price before formal recognition. In short, it would not surprise me (rather, I would expect) a financing package in the not too distant future, e.g. following a further significant contract or two, in order to bolster the balance sheet. I am not in a position to guess the likely placing (or open offer/rights if they're feeling kind to existing shareholders) but having been undersold and diluted on a number of occasions recently (IGP, IGE to name but two) I am wary of entering highly geared AIM companies at the present time, especially in tightening financial conditions. However, I shall continue to monitor and if they issue more paper I may well use any resulting dip as an entry opportunity. As a newcomer to the thread, I may be repeating (or perhaps contradicting) previous observations. Other views, either confirmatory or contrary, would be appreciated. | boadicea | |
01/7/2007 11:28 | I expect to see CLC trading in double figures this coming week. CLC will now bear the fruit of it's labours. | rolfe and nolan | |
01/7/2007 10:38 | There could be more news this week. Like another poster pointed out, once the software is fully developed it's 95% profit. | rolfe and nolan | |
29/6/2007 18:50 | Not looking bad, and the NHS news came after the US news. I'm holding for 24p. | redtif10 | |
29/6/2007 14:21 | Looks like the MM's are trying to suck people in. Online quote was 100k@6.5p earlier can now buy 200k for 6.35p. | relishing | |
29/6/2007 13:26 | Is this a buy then Orange? | relishing | |
29/6/2007 13:01 | Well, I never .... We've only gone out and won ourselves another contract! Let the mad buying frenzy begin. Today's AGM Statement in full: "Since the Company began its restructuring plan in the first half of 2005 the Group has reported steady progress with its operations and improving financial performance with losses decreasing steadily over each of the subsequent reporting periods. The following trading areas were noted by Howard Kitchner, Chairman: * The Company is expecting to report comparative period on period improvements to top line revenues for the six month period to 30 June 2007. This is in spite of the significant weakening of the US dollar, over the comparative periods. * During the first half of 2007 the Company has seen its US and Australian operations generating cash. At the present time the Company continues to fund its UK operations with debt. * Since the announcement of our 2006 final results on 27 April 2007, the Group has won a contract in the US to support the renal service department of a hospital with CLINIICAL VISION. Additionally, two customers have completed the implementation of CLINCIAL VISION. * The Group is now working through eight active CLINICAL VISION implementations, with a future revenue opportunity of over #1,000,000. * With respect to the UK market, the Company continues to build partnerships and work with our UK customer base on an upgrade programme from PROTON to CLINICAL VISION. With these trading conditions in mind the Board remains confident about the Group's prospects and continues to view the future with optimism." P.S. What good typists they have over at CLC: is the flagship product called CLINIICAL VISION or CLINCIAL VISION? | orange1 | |
22/6/2007 18:20 | Oh well. I only bought a few based on the NHS rumours. Should be a good punt in the long run. | redtif10 | |
22/6/2007 17:05 | but the NMS wont stop you buying a big wad at the moment. there is a massive overhang stock. you can buy upto 125k yet only sell 10k | cyberpost | |
22/6/2007 16:46 | "Any reason for such a low NMS?" To stop selling of a large number at the bid price without a requote? | bracke | |
22/6/2007 15:15 | so this is the share you were secretly emailing 'knowing' about ? | cyberpost | |
22/6/2007 14:19 | Event Dates: Annual general meeting 29 June 2007 Announcement of final results 27 April 2007 Announcement of interim results 21 September 2007 | rolfe and nolan |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions